{"id":59700,"date":"2021-08-05T00:00:00","date_gmt":"2021-08-05T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2021\/08\/05\/plasma-amyloid-beta-at-midlife-linked-to-later-mci-dementia\/"},"modified":"2021-08-09T15:11:48","modified_gmt":"2021-08-09T15:11:48","slug":"plasma-amyloid-beta-at-midlife-linked-to-later-mci-dementia","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2021\/08\/05\/plasma-amyloid-beta-at-midlife-linked-to-later-mci-dementia\/","title":{"rendered":"Plasma Amyloid-Beta at Midlife Linked to Later MCI, Dementia"},"content":{"rendered":"<h3>\n<p>Midlife measurements of plasma amyloid-beta may predict risk for mild cognitive impairment, dementia in late life<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, Aug. 5, 2021 (HealthDay News) &#8212; Plasma concentrations of amyloid-beta at midlife are associated with the risk for mild cognitive impairment (MCI) and dementia later in life, according to a study published online Aug. 4 in <em>Neurology<\/em>.<\/p>\n<p>Kevin J. Sullivan, Ph.D., M.P.H., from the University of Mississippi Medical Center in Jackson, and colleagues examined the association between midlife plasma A \u009f and the risk for MCI and dementia. In a subsample of the Atherosclerosis Risk in Communities cohort study, plasma A \u009f<sub>42<\/sub> and A \u009f<sub>40<\/sub> were measured retrospectively for 2,284 participants.<\/p>\n<p>The researchers found that each doubling of midlife A \u009f<sub>42<\/sub>:A \u009f<sub>40<\/sub> was associated with a significantly lower risk for MCI\/dementia (relative risk ratio, 0.63), only up to about the median (spline model threshold, 0.20). Each standard deviation increase in plasma A \u009f<sub>42<\/sub> (10 pg\/mL) was associated with a lower risk for MCI-dementia (relative risk ratio, 0.87), while a higher risk for MCI\/dementia was seen with every standard deviation increase in plasma A \u009f<sub>40 <\/sub>(67 pg\/mL; relative risk ratio, 1.15). When repeating models using late-life plasma A \u009f predictors, the associations were comparable but slightly weaker statistically.<\/p>\n<p>&#8220;A doubling of this ratio under this threshold at midlife was associated with a 37 percent lower risk of MCI or dementia, which is comparable to about five years of younger age, and a doubling of this ratio under this threshold at late life was comparable to about three years younger age,&#8221; Sullivan said in a statement. &#8220;Amyloid in the blood may be useful as a biomarker for risk of future cognitive impairment.&#8221;<\/p>\n<p>Several authors disclosed financial ties to the pharmaceutical industry.<\/p>\n<p><a href=\"https:\/\/n.neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000012482\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2021 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Midlife measurements of plasma amyloid-beta may predict risk for mild cognitive impairment, dementia in late life<\/p>\n","protected":false},"author":6,"featured_media":59895,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-59700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/59700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=59700"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/59700\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/59895"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=59700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=59700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=59700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}